Literature DB >> 17970070

Establishment and characterization of a new Ewing's sarcoma cell line from a malignant pleural effusion.

Roberta Schiavo1, Cinzia Tullio, Mariacarmela La Grotteria, Ines Chiara Andreotti, Barbara Scarpati, Lorenza Romiti, Fabio Bozzi, Paolo Pedrazzoli, Salvatore Siena.   

Abstract

BACKGROUND: Ewing's sarcoma cell lines may represent a good in vitro model for the understanding of tumor biology in this heterogeneous group of diseases. In the present study, we report the establishment and characterization of a primary Ewing's sarcoma cell line (LDS-Falck 01).
MATERIALS AND METHODS: LDS-Falck 01 was generated from a malignant pleural effusion of a patient with metastatic peripheral primitive neuroectodermal tumor arising from the chest wall. Extensive characterization of the cells was accomplished using immunocytochemical, RT-PCR and cytogenetic studies.
RESULTS: In vitro LDS-Falck 01 cells had both anchorage-dependent and -independent growth patterns. Immunocytochemical studies showed that cells were PAS-, vimentin-, CD99- and NSE-positive, EGFR- and CD117-negative. Cytogenetic analysis revealed a complex hyperdiploid karyotype with multiple chromosomal aberrations including an unbalanced translocation t(11;22)(q24;q12). The EWS/FLI1 chimeric transcript type 1 was detected.
CONCLUSION: This cell line may represent a valid tool for investigating the biomolecular characteristics of this group of neoplasms and their sensitivity to therapeutic agents.

Entities:  

Mesh:

Year:  2007        PMID: 17970070

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Molecular cytogenetic characterization of two established ESFT cell lines.

Authors:  Masako Ishiguro; Mutsumi Yuki; Tomoko Fukushige; Mikio Mizoguchi; Yasuhiko Kaneko; Takeshita Morishige; Hiroshi Iwasaki
Journal:  Hum Cell       Date:  2016-09-09       Impact factor: 4.174

2.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.